GA genotype of the Arg280His polymorphism on the XRCC1 gene: Genetic susceptibility genotype in differentiated thyroid carcinomas?

1Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States 1973-2002. JAMA. 2006; 295(18): 2164-2167.Davies L Welch HG Increasing incidence of thyroid cancer in the United States 1973-2002 JAMA 2006 295 18 2164 216710.1001/jama.295.18.216416684987Search in Google Scholar

2Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009; 16(2): 491-503.Akulevich NM Saenko VA Rogounovitch TI Drozd VM Lushnikov EF Ivanov VK et al Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma Endocr Relat Cancer 2009 16 2 491 50310.1677/ERC-08-033619286843Search in Google Scholar

3Lence-Anta JJ, Xhaard C, Ortiz RM, Kassim H, Pereda CM, Turcios S, et al. Environmental, lifestyle, and anthropometric riskfactors for differentiated thyroid cancer in cuba: a case-control study. Eur Thyroid J. 2014; 3(3): 189-196.Lence-Anta JJ Xhaard C Ortiz RM Kassim H Pereda CM Turcios S et al Environmental, lifestyle, and anthropometric riskfactors for differentiated thyroid cancer in cuba: a case-control study Eur Thyroid J 2014 3 3 189 196Search in Google Scholar

4Bashir K, Sarwar R, Fatima S, Saeed S, Mahjabeen I, Akhtar Kayani M. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma. J BUON. 2018; 23(1): 234-243.Bashir K Sarwar R Fatima S Saeed S Mahjabeen I Akhtar Kayani M Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma J BUON 2018 23 1 234 243Search in Google Scholar

5Matsuse M, Mitsutake N, Tanimura S, Ogi T, Nishihara E, Hirokawa M, et al. Functional characterization of the novel BRAF complexmutation, BRAF (V600 delinsYM), identified in papillarythyroid carcinoma. Int J Cancer. 2013; 132(3): 738-743.Matsuse M Mitsutake N Tanimura S Ogi T Nishihara E Hirokawa M et al Functional characterization of the novel BRAF complexmutation, BRAF (V600 delinsYM), identified in papillarythyroid carcinoma Int J Cancer 2013 132 3 738 74310.1002/ijc.2770922752848Search in Google Scholar

6Hu Z, Hu X, Long J, Su L, Wei B. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: A meta-analysis. Gene. 2013; 528(2): 67-73.Hu Z Hu X Long J Su L Wei B XRCC1 polymorphisms and differentiated thyroid carcinoma risk: A meta-analysis Gene 2013 528 2 67 7310.1016/j.gene.2013.07.00523872202Search in Google Scholar

7Du Y, Han LY, Li DD, Liu H, Gao YH, Sun D. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis. Asian Pac J Cancer Prev. 2013; 14(9): 5483-5487.Du Y Han LY Li DD Liu H Gao YH Sun D Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis Asian Pac J Cancer Prev 2013 14 9 5483 548710.7314/APJCP.2013.14.9.548324175846Search in Google Scholar

8Chang-Claud J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005; 11(13): 4802-4809.Chang-Claud J Popanda O Tan XL Kropp S Helmbold I von Fournier D et al Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients Clin Cancer Res 2005 11 13 4802 480910.1158/1078-0432.CCR-04-265716000577Search in Google Scholar

9Zhai W, Feng R, Wang H, Wang Y. Note of clarification of data in the papertitled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: An updated meta-analysis. Tumour Biol. 2015; 36(5): 3179-3189.Zhai W Feng R Wang H Wang Y Note of clarification of data in the papertitled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: An updated meta-analysis Tumour Biol 2015 36 5 3179 318910.1007/s13277-015-3384-425835974Search in Google Scholar

10Bu T, Liu L, Sun Y, Zhao L, Peng Y, Zhou S, et al. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: A meta-analysis of 10846 cases and 11723 controls. PLoS One. 2014; 9(1): e86086.Bu T Liu L Sun Y Zhao L Peng Y Zhou S et al XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: A meta-analysis of 10846 cases and 11723 controls PLoS One 2014 9 1 e8608610.1371/journal.pone.0086086390484824489692Search in Google Scholar

11Tian Z, Li YL, Liu JG. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Mol Biol Rep. 2013; 40(7): 4147-4151.Tian Z Li YL Liu JG XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population Mol Biol Rep 2013 40 7 4147 415110.1007/s11033-012-2463-523712778Search in Google Scholar

12Ho T, Li G, Lu J, Zhao C, Wei Q, Sturgis EM. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: A case-control analysis. Thyroid. 2009; 19(2): 129-135.Ho T Li G Lu J Zhao C Wei Q Sturgis EM Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: A case-control analysis Thyroid 2009 19 2 129 13510.1089/thy.2008.015319191745Search in Google Scholar

13Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin LC, et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 2008; 14(18): 5919-5924.Chiang FY Wu CW Hsiao PJ Kuo WR Lee KW Lin LC et al Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma Clin Cancer Res 2008 14 18 5919 592410.1158/1078-0432.CCR-08-0906Search in Google Scholar

14Garcia-Quispes WA, Perez-Machado G, Akdi A, Pastor S, Galofre P, Biarnes F, et al. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res. 2011: 709-710: 67-72.Garcia-Quispes WA Perez-Machado G Akdi A Pastor S Galofre P Biarnes F et al Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer Mutat Res 2011 709-710 67 7210.1016/j.mrfmmm.2011.03.003Search in Google Scholar

15Zhu QX, Bian JC, Shen Q, Pastor S, Galofré P, Zhang HW, et al. Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(8): 702-705.Zhu QX Bian JC Shen Q Pastor S Galofré P Zhang HW et al Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma Zhonghua Liu Xing Bing Xue Za Zhi 2004 25 8 702 705Search in Google Scholar

16Ryu RA, Tae K, Min HJ, Jeong JH, Cho SH, Lee SH, et al. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 2011; 26(8): 991-995.Ryu RA Tae K Min HJ Jeong JH Cho SH Lee SH et al XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample J Korean Med Sci 2011 26 8 991 99510.3346/jkms.2011.26.8.991Search in Google Scholar

17Zhu J, Qi P, Li Z. Interaction between XRCC1 gene polymorphisms and obesity on susceptibility to papillary thyroid cancer in Chinese Han population. Cell Physiol Biochem. 2018; 49(2): 638-644.Zhu J Qi P Li Z Interaction between XRCC1 gene polymorphisms and obesity on susceptibility to papillary thyroid cancer in Chinese Han population Cell Physiol Biochem 2018 49 2 638 64410.1159/000493027Search in Google Scholar

18Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Z, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res. 2009; 171(1): 77-88.Sigurdson AJ Land CE Bhatti P Pineda M Brenner A Carr Z et al Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan Radiat Res 2009 171 1 77 8810.1667/RR1327.1Search in Google Scholar

19Wang X, Zhang K, Liu X, Liu B, Wang Z. Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer. Int J Clin Exp Pathol. 2015; 8(3): 3160-3167.Wang X Zhang K Liu X Liu B Wang Z Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer Int J Clin Exp Pathol 2015 8 3 3160 3167Search in Google Scholar

20Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumour Biol. 2014;35:4791-7.Wang C Ai Z Association of XRCC1 polymorphisms with thyroid cancer risk Tumour Biol 2014354791 710.1007/s13277-014-1629-2Search in Google Scholar

21Yan L, Li Q, Li X, Ji H, Zhang L. Association studies between XRCC1, XRCC2, XRCC3 polymorphisms and differentiated thyroid carcinoma. Cell Physiol Biochem. 2016; 38(3): 1075-1084.Yan L Li Q Li X Ji H Zhang L Association studies between XRCC1, XRCC2, XRCC3 polymorphisms and differentiated thyroid carcinoma Cell Physiol Biochem 2016 38 3 1075 108410.1159/000443058Search in Google Scholar

22Fan J, Otterlei M, Wong HK, Tomkinson AE, Wilson DM 3rd. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acid Res. 2004; 32(7): 21932201.Fan J Otterlei M Wong HK Tomkinson AE Wilson DM 3rd XRCC1 co-localizes and physically interacts with PCNA Nucleic Acid Res 2004 32 7 2193220110.1093/nar/gkh556Search in Google Scholar

23Caldecott KW. XRCC1 and DNA strand repair. DNA Repair (Amst). 2003; 2(9): 955-969.Caldecott KW XRCC1 and DNA strand repair DNA Repair (Amst) 2003 2 9 955 96910.1016/S1568-7864(03)00118-6Search in Google Scholar

24Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphism in the base excision repair pathway and cancer risk. A HuGE review. Am J Epidemiol. 2005; 162(10): 925-942.Hung RJ Hall J Brennan P Boffetta P Genetic polymorphism in the base excision repair pathway and cancer risk A HuGE review. Am J Epidemiol 2005 162 10 925 94210.1093/aje/kwi31816221808Search in Google Scholar

25Yan L, Yanan D, Donglan S, Na W, Rongmiao Z, Zhifeng C. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus. 2009; 22(5): 396-401.Yan L Yanan D Donglan S Na W Rongmiao Z Zhifeng C Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma Dis Esophagus 2009 22 5 396 40110.1111/j.1442-2050.2008.00912.x19673050Search in Google Scholar

26Takanami T, Nakamura J, Kubota Y, Horiuchi S. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repairability. Mutat Res. 2005; 582(1-2): 135-145.Takanami T Nakamura J Kubota Y Horiuchi S The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repairability Mutat Res 2005 582 1-2 135 14510.1016/j.mrgentox.2005.01.00715781218Search in Google Scholar

27Zhang K, Zhou B, Wang Y, Rao L, Zhang L. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: An update by meta-analysis of 53 individual studies. Gene. 2012; 510(2): 93-101.Zhang K Zhou B Wang Y Rao L Zhang L The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: An update by meta-analysis of 53 individual studies Gene 2012 510 2 93 10110.1016/j.gene.2012.08.03922975644Search in Google Scholar

28Qian K, Liu KJ, Xu F, Chen XY, Chen GN, Yi WJ, et al. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and thyroid carcinoma risk: A meta-analysis. Asian Pac J Cancer Prev. 2012; 13(12): 6385-6390.Qian K Liu KJ Xu F Chen XY Chen GN Yi WJ et al X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and thyroid carcinoma risk: A meta-analysis Asian Pac J Cancer Prev 2012 13 12 6385 639010.7314/APJCP.2012.13.12.638523464463Search in Google Scholar

29Yang D, Han L-Y, Li D-D, Liu H, Gao YH, Sun DJ. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis. Asian Pac J Cancer Prev. 2013; 14(9): 5483-5487.Yang D Han L-Y Li D-D Liu H Gao YH Sun DJ Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis Asian Pac J Cancer Prev 2013 14 9 5483 548710.7314/APJCP.2013.14.9.548324175846Search in Google Scholar

30Hu Z, Hu X, Long J, Su L, Wei B. XRCC1 poly-morphisms and differentiated thyroid carcinoma risk: A meta-analysis. Gene. 2013; 528(2): 67-73.Hu Z Hu X Long J Su L Wei B XRCC1 poly-morphisms and differentiated thyroid carcinoma risk: A meta-analysis Gene 2013 528 2 67 7310.1016/j.gene.2013.07.00523872202Search in Google Scholar

31Bao Y, Jiang L, Zhou JY, Zou JJ, Zheng JY, Chen XF, et al. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): A meta-analysis of case-control studies. PLos One. 2013; 8(5): e64851.Bao Y Jiang L Zhou JY Zou JJ Zheng JY Chen XF et al XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): A meta-analysis of case-control studies PLos One 2013 8 5 e6485110.1371/journal.pone.0064851366146823717668Search in Google Scholar

32Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumor Biol. 2014; 35(5): 4791-4797.Wang C Ai Z Association of XRCC1 polymorphisms with thyroid cancer risk Tumor Biol 2014 35 5 4791 479710.1007/s13277-014-1629-224477575Search in Google Scholar

33Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003; 12(4): 359-365.Zhou W Liu G Miller DP Thurston SW Xu LL Wain JC et al Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk Cancer Epidemiol Biomarkers Prev 2003 12 4 359 365Search in Google Scholar

34Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch Surg. 1955; 70(2): 291-297.Dailey ME Lindsay S Skahen R Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland Arch Surg 1955 70 2 291 29710.1001/archsurg.1955.0127008013702313227748Search in Google Scholar

35Cheema Y, Olson S, Elson D, Chen H. What is the biology and optimal treatment for papillary micro-carcinoma of the thyroid? J Surg Res. 2006; 134(2): 160-162.Cheema Y Olson S Elson D Chen H What is the biology and optimal treatment for papillary micro-carcinoma of the thyroid? J Surg Res 2006 134 2 160 16210.1016/j.jss.2006.04.01416780882Search in Google Scholar

36Jankovic B, Le KT, Hershman JM. Clinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation? J Clin Endocrinol Metab. 2013; 98(2): 474-482.Jankovic B Le KT Hershman JM Clinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation? J Clin Endocrinol Metab 2013 98 2 474 48210.1210/jc.2012-297823293329Search in Google Scholar